Would Open Science Solve Bottlenecks In Developing Biopharmaceutical Products?
Thursday, August 21, 2014 - 11:31
in Mathematics & Economics
Due to increased regulations, a culture war against pharmaceutical corporations, and the high costs of trials, companies have increasingly allowed early taxpayer-funded biomedical research to spread the risk among hundreds of millions of people. The pace of invention has slowed considerably and it may be because of academic culture, according to a new study. An analysis of patented university inventions has revealed early bottlenecks on the path to commercialization and the authors suggest that better communication of basic research results during the discovery stage could lead to faster commercialization down the road. read more